SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-023095
Filing Date
2024-04-29
Accepted
2024-04-29 17:06:04
Documents
6
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20024289x1_def14a.htm DEF 14A 1113451
2 logo_ardelyxsymbol.jpg GRAPHIC 20032
3 ny20024289x1_pc01.jpg GRAPHIC 635569
4 ny20024289x1_pc02.jpg GRAPHIC 407225
5 ny20024289x1_pvp01.jpg GRAPHIC 159469
6 ny20024289x1_pvp02.jpg GRAPHIC 157523
  Complete submission text file 0001140361-24-023095.txt   3013637
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36485 | Film No.: 24892453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)